Today, Benzinga's options scanner spotted 9 options trades for Amgen. This is not a typical pattern. The sentiment among ...

Amgen (AMGN) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

Amgen (AMGN) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

When you buy and hold a stock for the long term, you definitely want it to provide a positive return. But more ...

Amgen (AMGN) closed at $280.19 in the latest trading session, marking a -1.22% move from the prior day. The stock's performance was behind the S&P 500's daily gain of 0.21%. Elsewhere, the Dow saw an ...

Amgen (NASDAQ: AMGN) has outperformed the market over the past 15 years by 1.0% on an annualized basis producing an average annual return of 13.12%. Currently, Amgen has a market capitalization of ...

In addition to Scotiabank, Amgen also received a Buy from Piper Sandler’s David Amsellem in a report issued yesterday. However, on the same day, Truist Financial maintained a Hold rating on Amgen ...

Amgen Inc. (NASDAQ: AMGN) just delivered a strong beat-and-raise quarter. That’s pushed the stock to within striking distance of its 52-week high. That also puts it within striking distance of a ...

Though Amgen AMGN and Viking Therapeutics VKTX do not currently market any obesity drugs, they are among the few biotechs that have shown immense potential in this space. Amgen boasts a strong ...